{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:43:34Z","timestamp":1784958214187,"version":"3.55.0"},"reference-count":51,"publisher":"Bioscientifica","issue":"4","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":375,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Gonadal dysfunction is a major late complication after cancer diagnosis and treatment. We aimed to study the prevalence of premature ovarian insufficiency (POI) and the potential reduction of ovarian reserve in a cohort of adolescent and young adult (AYA) patients undergoing cancer treatments, evaluating ovarian function and reserve markers. We also aimed to analyze how these markers are related to each other and to treatment-related risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a retrospective study, including all female AYA patients undergoing cancer treatment during childhood or adolescence, who visited our pediatric gynecology outpatient clinic between January 1, 2018, and August 30, 2023. Serum levels of anti-Mullerian hormone (AMH) and follicle-stimulating hormone (FSH), antral follicle count (AFC) and mean ovarian volume were evaluated. The correlations between these markers and how their alterations are related to treatment-related risk factors were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The prevalence of POI in 95 patients was 18.9%. A significant positive correlation was observed between AMH levels and both AFC and ovarian volume. AMH was the most reliable serum marker for ovarian function in terms of POI. Independent risk factors for ovarian dysfunction in relation to all the markers analyzed were hematopoietic stem cell transplantation (HSCT) and high doses of alkylating agents (\u22656000 mg\/m2).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Gonadal dysfunction and infertility are quite common in AYA patients undergoing cancer treatment. High-dose alkylating agents and HSCT are the independent risk factors. AMH and FSH values, AFC and mean ovarian volume provide different but consistent information for closely monitoring patients after cancer treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/ec-24-0511","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T10:10:19Z","timestamp":1738318219000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":1,"title":["Ovarian function in adolescents and young adults undergoing cancer treatment: biochemical and ultrasound marker analysis"],"prefix":"10.1530","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2472-7888","authenticated-orcid":true,"given":"Claudia","family":"Signorino","sequence":"first","affiliation":[{"name":"1 Auxo-Endocrinology Unit, Meyer Children's Hospital IRCCS, Florence, Italy"},{"name":"Pediatrics and Neonatology Unit, Santo Stefano Hospital, AUSL Toscana Centro 2 , ,","place":["Prato, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Bencini","sequence":"additional","affiliation":[{"name":"3 Pediatric Gynecology, Prenatal Diagnosis and Congenital Defects Unit, Meyer Children's Hospital IRCCS, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Tondo","sequence":"additional","affiliation":[{"name":"4 Department of Pediatric Oncology and Haematology, Meyer Children's Hospital IRCCS, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perla","family":"Scalini","sequence":"additional","affiliation":[{"name":"4 Department of Pediatric Oncology and Haematology, Meyer Children's Hospital IRCCS, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Tamburini","sequence":"additional","affiliation":[{"name":"4 Department of Pediatric Oncology and Haematology, Meyer Children's Hospital IRCCS, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Casini","sequence":"additional","affiliation":[{"name":"4 Department of Pediatric Oncology and Haematology, Meyer Children's Hospital IRCCS, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Sardi","sequence":"additional","affiliation":[{"name":"5 Neuro-Oncology Unit, Meyer Children's Hospital IRCCS, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2259-4685","authenticated-orcid":true,"given":"Stefano","family":"Stagi","sequence":"additional","affiliation":[{"name":"1 Auxo-Endocrinology Unit, Meyer Children's Hospital IRCCS, Florence, Italy"},{"name":"6 Department of Health Sciences, University of Florence, Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"key":"2026070710573616700_bib1","volume-title":"Cancer Today","author":"Ferlay"},{"key":"2026070710573616700_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112607","article-title":"Childhood cancer: occurrence, treatment and risk of second primary malignancies","volume":"13","author":"Zahnreich","year":"2021","journal-title":"Cancers"},{"key":"2026070710573616700_bib3","volume-title":"Late effects of treatment for childhood cancer (PDQ)\u2013health professional version","author":"National Cancer Institute"},{"key":"2026070710573616700_bib4","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/women4020009","article-title":"Endogenous hormones and cognitive decline in women: unveiling the complex interplay","volume":"4","author":"Targonskaya","year":"2024","journal-title":"Women"},{"key":"2026070710573616700_bib5","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0140-6736(10)60355-8","article-title":"Primary ovarian insufficiency","volume":"376","author":"De Vos","year":"2010","journal-title":"Lancet"},{"key":"2026070710573616700_bib6","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1089\/jayao.2020.0012","article-title":"Standardizing risk assessment for treatment-related gonadal insufficiency and infertility in childhood adolescent and young adult cancer: the pediatric initiative network risk stratification system","volume":"9","author":"Meacham","year":"2020","journal-title":"J Adolesc Young Adult Onco"},{"key":"2026070710573616700_bib7","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/S1470-2045(20)30594-5","article-title":"Fertility preservation for female patients with childhood, adolescent, and young adult cancer: recommendations from the PanCareLIFE consortium and the international late effects of childhood cancer guideline harmonization group","volume":"22","author":"Mulder","year":"2021","journal-title":"Lancet Oncol"},{"key":"2026070710573616700_bib8","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1530\/RAF-22-0020","article-title":"Potential ovarian toxicity and infertility risk following targeted anti-cancer therapies","volume":"3","author":"Rosario","year":"2022","journal-title":"Reprod Fertil"},{"key":"2026070710573616700_bib9","volume-title":"Compiled by members of the Late Effects Group for the CCLG","author":"Brougham","year":"2019"},{"key":"2026070710573616700_bib10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11764-014-0354-6","article-title":"Male infertility in long-term survivors of pediatric cancer: a report from the childhood cancer survivor study","volume":"8","author":"Wasilewski-Masker","year":"2014","journal-title":"J Cancer Surviv"},{"key":"2026070710573616700_bib11","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s11764-015-0506-3","article-title":"Sexual health problems in French cancer survivors 2 years after diagnosis-the national VICAN survey","volume":"10","author":"Ben Charif","year":"2016","journal-title":"J Cancer Surviv Res Pract"},{"key":"2026070710573616700_bib12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s12094-021-02699-2","article-title":"Multidisciplinary consensus on the criteria for fertility preservation in cancer patients","volume":"24","author":"Santaballa","year":"2022","journal-title":"Clin Transl Oncol"},{"key":"2026070710573616700_bib13","doi-asserted-by":"crossref","DOI":"10.1186\/s13048-018-0430-z","article-title":"Discordant anti-M\u00fcllerian hormone (AMH) and follicle stimulating hormone (FSH) among women undergoing in vitro fertilization (IVF): which one is the better predictor for live birth?","volume":"11","author":"Wang","year":"2018","journal-title":"J Ovarian Res"},{"key":"2026070710573616700_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.601752","article-title":"Ovarian reserve markers in premature ovarian insufficiency: within different clinical stages and different etiologies","volume":"12","author":"Jiao","year":"2021","journal-title":"Front Endocrinol"},{"key":"2026070710573616700_bib15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/humrep\/17.1.118","article-title":"A moderately elevated day 3 FSH concentration has limited predictive value, especially in younger women","volume":"17","author":"Esposito","year":"2002","journal-title":"Hum Reprod"},{"key":"2026070710573616700_bib16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1210\/clinem\/dgab687","article-title":"Clinical utility of anti-Mullerian hormone in pediatrics","volume":"107","author":"Kanakatti Shankar","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070710573616700_bib17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/gme.0b013e31824d8f40","article-title":"Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging","volume":"19","author":"Harlow","year":"2012","journal-title":"Menopause"},{"key":"2026070710573616700_bib18","doi-asserted-by":"crossref","first-page":"992","DOI":"10.4143\/crt.2022.1518","article-title":"Gonadal function in female adolescent and young adult survivors of childhood cancer","volume":"55","author":"Jin","year":"2023","journal-title":"Cancer Res Treat"},{"key":"2026070710573616700_bib19","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.fertnstert.2020.09.134","article-title":"Testing and interpreting measures of ovarian reserve: a committee opinion","volume":"114","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2020","journal-title":"Fertil Steril"},{"key":"2026070710573616700_bib20","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/j.fertnstert.2007.10.028","article-title":"Establishing the intercycle variability of three- dimensional ultrasonographic predictors of ovarian reserve","volume":"90","author":"Jayaprakasan","year":"2008","journal-title":"Fertil Steril"},{"key":"2026070710573616700_bib21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/pbc.24679","article-title":"The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study","volume":"61","author":"Green","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"2026070710573616700_bib22","volume-title":"Infertility Workup for the Women's Health Specialist: ACOG Committee Opinion","author":"American College of Obstetricians and Gynecologists","year":"2023"},{"key":"2026070710573616700_bib23","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejogrb.2010.02.029","article-title":"The use of anti-M\u00fcllerian hormone and antral follicle count to predict the potential of oocytes and embryos","volume":"150","author":"Majumder","year":"2010","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2026070710573616700_bib24","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.rard.2016.10.002","article-title":"Antral follicle count as a predictor of ovarian response","volume":"80","author":"Lonegro","year":"2016","journal-title":"Rev Argent Radiol"},{"key":"2026070710573616700_bib25","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1210\/jc.2016-3723","article-title":"Premature ovarian insufficiency in childhood cancer survivors: a report from the St. Jude lifetime cohort","volume":"102","author":"Chemaitilly","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070710573616700_bib26","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/humrep\/dey229","article-title":"Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserve","volume":"33","author":"Van den Berg","year":"2018","journal-title":"Hum Reprod"},{"key":"2026070710573616700_bib27","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/ijc.34541","article-title":"Premature ovarian insufficiency and chance of pregnancy after childhood cancer: a population-based study (the Fex-Can study)","volume":"153","author":"Haavisto","year":"2023","journal-title":"Int J Cancer"},{"key":"2026070710573616700_bib28","first-page":"982","article-title":"Assessment of ovarian reserve in adult childhood cancer survivors using anti-M\u00fcllerian hormone","volume":"24","author":"Lie","year":"2009","journal-title":"Hum Reprod"},{"key":"2026070710573616700_bib29","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/cncr.31121","article-title":"Nonsurgical premature menopause and reproductive implications in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study","volume":"124","author":"Levine","year":"2018","journal-title":"Cancer"},{"key":"2026070710573616700_bib30","doi-asserted-by":"crossref","first-page":"5307","DOI":"10.1210\/jc.2003-030352","article-title":"Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer","volume":"88","author":"Larsen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070710573616700_bib31","first-page":"193","article-title":"Longitudinal follow-up in female childhood cancer survivors: No signs of accelerated ovarian function loss","volume":"32","author":"van der Kooi","year":"2017","journal-title":"Hum Reprod"},{"key":"2026070710573616700_bib32","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1080\/0284186X.2018.1529423","article-title":"Anti-M\u00fcllerian hormone compared with other ovarian markers after childhood cancer treatment","volume":"58","author":"Nystr\u00f6m","year":"2019","journal-title":"Acta Oncol"},{"key":"2026070710573616700_bib33","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/humupd\/dmt037","article-title":"Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice","volume":"20","author":"La Marca","year":"2014","journal-title":"Hum Reprod Update"},{"key":"2026070710573616700_bib34","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.rbmo.2015.06.015","article-title":"Assessing ovarian response: antral follicle count versus anti-M\u00fcllerian hormone","volume":"31","author":"Fleming","year":"2015","journal-title":"Reprod Biomed Online"},{"key":"2026070710573616700_bib35","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/AOG.0b013e3182116bc8","article-title":"Anti-M\u00fcllerian hormone as a predictor of natural fecundability in women aged 30-42 years","volume":"117","author":"Steiner","year":"2011","journal-title":"Obstet Gynecol"},{"key":"2026070710573616700_bib36","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jpag.2016.04.009","article-title":"Anti-M\u00fcllerian hormone in female adolescent cancer patients before, during, and after completion of therapy: a pilot feasibility study","volume":"29","author":"Gupta","year":"2016","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"2026070710573616700_bib37","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1210\/clinem\/dgaa172","article-title":"Modeling variation in the reproductive lifespan of female adolescent and young adult cancer survivors using AMH","volume":"105","author":"Su","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070710573616700_bib38","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/pbc.25162","article-title":"Ovarian insufficiency and pubertal development after hematopoietic stem cell transplantation in childhood","volume":"61","author":"Bresters","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"2026070710573616700_bib39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/jayao.2023.0111","article-title":"Ovarian insufficiency and fertility preservation during and after childhood cancer treatment","volume":"13","author":"Foster","year":"2024","journal-title":"J Adolesc Young Adult Oncol"},{"key":"2026070710573616700_bib40","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.critrevonc.2018.09.020","article-title":"Fertility preserving options for gynecologic malignancies: a review of current understanding and future directions","volume":"132","author":"McKenzie","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"2026070710573616700_bib41","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2006-2374","article-title":"Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood","volume":"92","author":"van Beek","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070710573616700_bib42","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10815-015-0636-6","article-title":"Fertility in young patients following treatment for Hodgkin's lymphoma: a single center survey","volume":"33","author":"Bolte\u017ear","year":"2016","journal-title":"J Assist Reprod Genet"},{"key":"2026070710573616700_bib43","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.gyobfe.2010.09.002","article-title":"Unknown gonadotoxicity chemotherapy and preservation of fertility: example of Temozolomide","volume":"38","author":"Sitbon","year":"2010","journal-title":"Gynecol Obstet Fertil"},{"key":"2026070710573616700_bib44","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/09513590.2018.1531985","article-title":"Successful in vitro maturation for urgent fertility preservation despite hormonal contraception by continuous progestin application","volume":"35","author":"Roesner","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"2026070710573616700_bib45","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3892\/mco.2017.1237","article-title":"Ovarian function following targeted anti-angiogenic therapy with bevacizumab","volume":"6","author":"Imai","year":"2017","journal-title":"Mol Clin Oncol"},{"key":"2026070710573616700_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.641450","article-title":"Fertility preservation in female pediatric patients with cancer: a clinical and regulatory issue","volume":"11","author":"Brancati","year":"2021","journal-title":"Front Oncol"},{"key":"2026070710573616700_bib47","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1200\/JCO.2012.43.5511","article-title":"Female reproductive health after childhood, adolescent, and young adult cancers: guidelines for the assessment and management of female reproductive complications","volume":"31","author":"Metzger","year":"2013","journal-title":"J Clin Oncol"},{"key":"2026070710573616700_bib48","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.fertnstert.2016.09.046","article-title":"Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause","volume":"106","author":"Sullivan","year":"2016","journal-title":"Fertil Steril"},{"key":"2026070710573616700_bib49","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1200\/JCO.2018.78.1914","article-title":"Fertility preservation in patients with cancer: ASCO clinical practice guideline update","volume":"36","author":"Oktay","year":"2018","journal-title":"J Clin Oncol"},{"key":"2026070710573616700_bib50","doi-asserted-by":"crossref","first-page":"7792","DOI":"10.3390\/ijms21207792","article-title":"Advances in the treatment and prevention of chemotherapy-induced ovarian toxicity","volume":"21","author":"Cho","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026070710573616700_bib51","volume-title":"Long-term follow-up guidelines for survivors of pediatric, adolescent, and young adult cancers","author":"Children\u2019s Oncology Group","year":"2018"}],"container-title":["Endocrine Connections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/14\/4\/EC-24-0511.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/14\/4\/EC-24-0511.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-24-0511\/9333\/ec-24-0511.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article-pdf\/doi\/10.1530\/EC-24-0511\/9333\/ec-24-0511.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:19:56Z","timestamp":1783437596000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/ec\/article\/14\/4\/e240511\/1367\/Ovarian-function-in-adolescents-and-young-adults"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1530\/ec-24-0511","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]},"article-number":"e240511"}}